H.R. 1143: Medicare IVIG Access Enhancement Act of 2025
Latest action, February 7, 2025: Introduced in House
Official summary
Medicare IVIG Access Enhancement Act of 2025 This bill provides for Medicare coverage of in-home administration of intravenous immune globulin to treat chronic inflammatory demyelinating polyneuropathy (CIDP) or multifocal motor neuropathy. (CIDP is an autoimmune condition that causes symptoms such as muscle weakness and numbness; multifocal motor neuropathy is a variant of CIDP that only causes asymmetric muscle weakness.)